Researchers assessed the total effect of bipolar disorder and major depression on cognitive function in adults between 40 and 69 years old and measured the effects mediated by psychotropic drug use and cardiometabolic disease.
Cognition and memory loss do not demonstrate adverse effects with evolocumab and statin therapy.
Dr. Roger McIntyre suggests that the clinical relevance of cognitive dysfunction for any individual patient can only be adjudicated on a case-by-case basis.
Dysfunction across several cognitive domains is often concomitant with depression.
Most aging humans will develop some degree of decline in cognitive capacity.
Investigators used fMRI to examine whether disruption of long-term fear memory reconsolidation can attenuate the activity in the amygdala at re-exposure to fear cues.
Tetrahydrocannabinol (THC) is the main active chemical ingredient found in cannabis and is a potent cannabinoid receptor (CB)-1 agonist.
The memory-enhancing effects of methylene blue have previously been associated with improvement of memory consolidation.
The current findings are in line with previous studies reporting beneficial effects of physical exercise on memory acquisition, consolidation, reconsolidation, and retrieval.
Study participants with moderate to severe anxiety exhibited poor visual and verbal memory.
